Identification of Iclusig:

No description

Search images on Google      Product Monograph

Active Ingredients:

• ponatinib (ponatinib hydrochloride), 15 MG

DIN: 02437333

Dosage Form(s): TABLET

Route(s) of Administration: ORAL

Schedule: Prescription

Company: TAKEDA PHARMACEUTICALS U.S.A., INC.

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01E - (ATC, WHO)
• L01EA - (ATC, WHO)
• L01EA05 - PONATINIB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 60/180

 

External Links for Iclusig:

Search on Google

• Iclusig side effects
• Iclusig dosage
• ponatinib side effects
• ponatinib dosage